My laboratory addresses biochemical mechanisms that contribute to chronic lung inflammation and remodeling.The laboratory emphasizes the role of epithelial cells and oxidative stress. A major goal is to develop redox-based therapeutics that can be used clinically to treat patients with chronic lung disease, such as asthma, COPD, lung fibrosis and lung cancer.

Here is our mission statement:
Research: To unravel the molecular basis of diverse pulmonary diseases that are characterized by chronic fibrotic remodeling by emphasizing the biology of epithelial cells and redox-dependent processes.

Education: To provide an exciting research environment and extensive mentoring to all laboratory members to enable each of them to be maximally successful in the arena of biomedical sciences in diverse capacities.

Product development: We have a number of patented small molecules and are passionate to advance these as potential drugs to treat fibrotic lung diseases. Laboratory members have the opportunities to work with a number of companies in order to acquire expertise in drug development.

Values: We work as a close-knit team, and together strive to advance knowledge and to have a positive impact on the lives of people with chronic lung disease. We are highly dedicated group of professionals who work hard, and know how to have fun.